ABSI CIK: 1672688

Absci Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−60.6
FY22:
−81.3
FY23:
−64.6
FY24:
−72.4
FY25:
−92.9
Change from FY21 to FY25
millions USD
FY21:
−67.4
FY22:
−127
FY23:
81.9
FY24:
−41.6
FY25:
−50.2
Change from FY21 to FY25
millions USD
FY21:
336
FY22:
5.24
FY23:
−4.48
FY24:
82.5
FY25:
106
millions USD
FY21:
208
FY22:
−203
FY23:
12.8
FY24:
−31.5
FY25:
−37.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−98.6
FY22:
−97.5
FY23:
−65.5
FY24:
−72.8
FY25:
−94.0

All amounts in millions USD Data source:SEC EDGAR